AMGEN Inc
NASDAQ: AMGN
$335.61
-$1.77 (-0.5%)
Closing Price on September 23, 2024
AMGN Articles
The following are some of the top stocks to watch for active trading today based on pre-market and after-hours volume activity. There are links through to more detailed coverage and volume analysis...
Published:
Reuters: The recession has badly hurt investments in green technologies. Reuters: Obama called for deeper China ties with the US. Reuters: BP’s (BP) profits fell sharply. Reuters: ...
Published:
Last Updated:
Bristol Myers Inc. (NYSE: BMY) plans to spend $2.4 billion to buy partner Medarex Inc. (Nasdaq: MEDX). It will get a great deal beyond the cancer monoclonal antibody that developed together. The...
Published:
Last Updated:
Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line data, a new biotech-based treatment, and a massive potential market....
Published:
Last Updated:
These are some of the top stories affecting key drug and biotech stocks that are covered with more in-depth details and analysis this morning at BioHealthInvestor.com: Amgen Inc’s (Nasdaq:...
Published:
These are some of the top stocks for day traders and active traders to watch based on pre-market and after-hours volume activity with links to more detailed price and volume analysis on each...
Published:
Novartis AG (NYSE: NVS) shares are at session highs and well of the lows of the day in the early afternoon Thursday after Japan okayed one of the company’s human growth hormones, the first approval...
Published:
We have compiled an updated lengthy 2009 American Society of Clinical Oncology, or ASCO, document showing many company cancer data presentations slated to start this weekend. This is broken down...
Published:
These are some of the top pre-market analyst upgrades and positive research calls we have seen from Wall Street this Wednesday morning with more than two hours until the market opens: Alcatel-Lucent...
Published:
These are among the top research calls and analyst upgrades and downgrades we have seen early this Friday morning with over two hours until the open: Amgen (AMGN) Raised to Outperform at Baird....
Published:
Amgen Inc. (NASDAQ: AMGN) has posted some very highly anticipated and uninteresting earnings. The biotech giant reported $0.98 EPS net and $1.08 non-GAAP EPS on $3.31 billion in revenue, while...
Published:
Last Updated:
This weekend will be a potentially important oncology and cancer news weekend for drug and biotech stocks. The American Association for Cancer Research Meeting will actually have a 100th annual...
Published:
These are ten of the top impact research calls with upgrades and downgrades from Wall Street early this Friday morning: Amgen (AMGN) Raised to Overweight at JPMorgan. ConocoPhillips (COP) Raised to...
Published:
Layoffs at big companies are so common now that it is novel when a day goes by without Microsoft (MSFT), Caterpillar (CAT), or Macy’s (MC) letting thousands of people go. There are a relatively...
Published:
Last Updated:
Biogen Idec Inc. (NASDAQ: BIIB) is set to report earnings on Friday morning. What many investors probably want to know is if these results — or more importantly its guidance — show that this...
Published:
Last Updated: